V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006224 | 300004311 | 1.61 | 66.1 | Palliative (P) | 2015-03-25 | 2015-03-29 | Carboplatin AUC 2 - 5 | N | N | 300015282 | CAPECITABINE |
| 300006225 | 300004311 | 0 | null | null | null | 2016-09-05 | Carboplatin AUC 6 - 10 | null | null | 300015282 | DE-ESCALATE TRIAL |
| 300006226 | 300004312 | 1.8 | 78 | Palliative (P) | 2017-03-01 | 2017-03-14 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015288 | TEMOZOLOMIDE |
| 300006227 | 300004314 | 1.56 | 66 | Palliative (P) | 2016-03-28 | 2016-04-04 | Irinotecan + Modified De Gramont | 02 | N | 300015288 | CISPLATIN + FLUOROURACIL |
| 300006228 | 300004315 | 1.82 | 77.3 | Palliative (P) | 2013-11-09 | 2013-11-09 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 300015302 | CISPLATIN |
| 300006229 | 300004317 | 1.52 | 75 | Palliative (P) | 2018-06-28 | 2018-08-11 | Fluorouracil + Folinic Acid (Mayo) | N | null | 300015303 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006230 | 300004318 | 1.67 | 107.3 | Palliative (P) | null | 2015-01-08 | Capecitabine | N | N | 300015310 | CAV |
| 300006231 | 300004319 | 1.82 | null | Palliative (P) | 2013-06-29 | 2013-12-28 | Oxaliplatin + Modified de Gramont | 2 | N | 300015317 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300006232 | 300004320 | 1.7 | 87.3 | Adjuvant (A) | 2016-08-20 | 2016-08-29 | Carboplatin + Cetux + FU (>Cycle 2) | 2 | N | 300015346 | CETUXIMAB + CISPLATIN + FU |
| 300006233 | 300004320 | 1.77 | 62 | Palliative (P) | 2013-07-17 | 2013-07-28 | Carbo F | null | null | 300015346 | CETUXIMAB + RT |
| 300006234 | 300004322 | 1.64 | 67.45 | Palliative (P) | 2014-12-21 | 2015-01-03 | Gemcitabine + Oxaliplatin | N | N | 300015352 | DOCETAXEL |
| 300006235 | 300004322 | null | null | Palliative (P) | 2017-04-15 | 2017-04-17 | GemCarbo Days 1+8 | Y | N | 300015352 | METHOTREXATE HIGH DOSE |
| 300006236 | 300004323 | 1.6 | 101 | Palliative (P) | 2016-08-18 | 2016-09-14 | FCarboSt | N | N | 300015356 | CISPLATIN + FLUOROURACIL |
| 300006237 | 300004323 | 1.79 | 82.6 | Neo-adjuvant (N) | 2016-10-09 | 2016-10-22 | Carboplatin + Etoposide IV 3 day | 02 | N | 300015356 | CISPLATIN + FLUOROURACIL |
| 300006238 | 300004324 | 1.83 | 69.4 | Curative (C) | 2017-10-08 | 2017-11-15 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 300015369 | CISPLATIN + FLUOROURACIL |
| 300006239 | 300004325 | 1.57 | 70.6 | Palliative (P) | 2018-03-31 | 2018-03-31 | Gemcitabine + Capecitabine | 02 | N | 300015398 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006240 | 300004325 | 1.84 | 119.2 | Palliative (P) | 2018-07-11 | 2018-07-12 | Bevacizumab 5mg/kg | 02 | N | 300015398 | PACLITAXEL |
| 300006243 | 300004330 | 1.56 | 77 | Not known (9) | 2014-04-30 | 2014-05-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300015419 | DE-ESCALATE TRIAL |
| 300006244 | 300004331 | 1.78 | 90 | Palliative (P) | 2014-12-27 | 2014-12-27 | CAPECITABINE + OXALIPLATIN | 02 | N | 300015434 | OXALIPLATIN + MDG |
| 300006245 | 300004331 | 1.69 | 82 | Curative (C) | 2015-05-26 | 2015-05-26 | FCarboSt | 2 | N | 300015434 | TRIAL |
| 300006246 | 300004331 | 1.46 | 69.9 | Palliative (P) | 2016-01-07 | 2017-11-04 | Trial Unspecified | 2 | N | 300015434 | CISPLATIN + FLUOROURACIL |
| 300006247 | 300004331 | 1.55 | 40 | Palliative (P) | 2016-05-30 | 2016-06-27 | Cisplatin | Y | N | 300015434 | CISPLATIN + FLUOROURACIL |
| 300006249 | 300004334 | 1.71 | 60.2 | Curative (C) | 2013-07-09 | 2013-07-18 | Trial Unspecified | 01 | N | 300015466 | CARBOPLATIN |
| 300006250 | 300004335 | 1.74 | 94.7 | Palliative (P) | 2015-12-01 | 2015-12-06 | Folfirinox | 2 | N | 300015479 | BEVACIZUMAB |
| 300006251 | 300004336 | 1.85 | 88.3 | Curative (C) | 2018-06-07 | 2018-06-12 | CAPECITABINE + OXALIPLATIN | 1 | N | 300015484 | BEVACIZUMAB |
| 300006252 | 300004337 | 1.78 | 68 | Palliative (P) | 2013-02-16 | 2013-03-26 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 300015484 | CAPECITABINE + OXALIPLATIN |
| 300006253 | 300004340 | null | 59.4 | Curative (C) | 2014-04-23 | 2014-04-27 | Cisplatin 7 day | 02 | Y | 300015501 | CISPLATIN |
| 300006254 | 300004341 | 1.67 | 70.6 | Adjuvant (A) | 2014-04-05 | 2014-04-14 | ESPAC-4 TRIAL | 02 | null | 300015502 | DE-ESCALATE TRIAL |
| 300006255 | 300004341 | 1.63 | 76.2 | Palliative (P) | 2013-09-13 | 2013-09-13 | CAPECITABINE + OXALIPLATIN | 02 | N | 300015502 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 300006256 | 300004341 | 1.58 | 45.7 | Curative (C) | 2017-02-15 | 2017-04-30 | Folfirinox | N | N | 300015502 | CAPECITABINE |
| 300006257 | 300008262 | null | null | null | 2013-12-20 | 2014-06-04 | CARBOPLATIN | N | N | 300015526 | ESPAC TRIAL |
| 300006258 | 300004342 | 1.51 | 49 | Adjuvant (A) | 2016-05-29 | 2016-08-04 | Gemcitabine + Capecitabine | 02 | N | 300015527 | MELPHALAN |
| 300006259 | 300004343 | 1.78 | null | Curative (C) | 2015-01-14 | 2015-01-18 | CompARE Trial | N | N | 300015528 | TRIAL |
| 300006260 | 300004344 | 1.78 | 74.5 | Palliative (P) | 2015-12-05 | 2015-12-15 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 300015534 | CARBOPLATIN + RT |
| 300006262 | 300004347 | 1.63 | null | Palliative (P) | 2015-10-11 | 2015-10-26 | Trial Unspecified | N | N | 300015542 | CISPLATIN |
| 300006263 | 300004348 | 1.81 | 81 | Palliative (P) | null | 2016-11-18 | GemCarbo Days 1+8 | Y | N | 300015543 | OXALIPLATIN + MDG |
| 300006264 | 300004350 | 1.92 | 60.4 | Curative (C) | 2013-12-31 | 2014-01-26 | Trial Unspecified | null | Y | 300015546 | CISPLATIN |
| 300006265 | 300004351 | 1.68 | 81.9 | Curative (C) | 2015-03-28 | 2015-03-28 | Carboplatin AUC 2 - 5 | N | Y | 300015550 | CISPLATIN |
| 300006266 | 300006807 | null | 52.7 | Curative (C) | 2013-05-02 | 2013-05-23 | Gemcitabine + Capecitabine | N | N | 300015557 | CARBOPLATIN + CETUXIMAB + FU |
| 300006267 | 300004352 | 1.69 | 59.15 | Palliative (P) | 2017-11-20 | 2017-12-05 | Cyclophosphamide + Docetaxel | Y | N | 300015568 | CHLVPP |
| 300006268 | 300006808 | 1.71 | 94.1 | Palliative (P) | 2018-06-01 | 2018-06-11 | BCG Intravesical | N | N | 300015571 | CARBOPLATIN |
| 300006269 | 300004354 | null | 69 | Curative (C) | 2013-06-11 | 2013-07-16 | NIVOLUMAB | N | N | 300015578 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006270 | 300004356 | 1.62 | 42.3 | Curative (C) | 2013-11-19 | 2013-11-20 | CARBOPLATIN + ETOPOSIDE | 02 | N | 300015583 | CAPECITABINE |
| 300006271 | 300004357 | 1.72 | 66 | Curative (C) | 2017-02-26 | 2017-03-30 | Carboplatin AUC 6 - 10 | 02 | null | 300015592 | CARBOPLATIN |
| 300006272 | 300004360 | 1.69 | 72.6 | Palliative (P) | 2014-09-09 | 2014-09-16 | Oxaliplatin + Modified de Gramont | 02 | N | 300015592 | TRIAL |
| 300006273 | 300004361 | 1.75 | null | null | 2013-03-03 | 2013-03-25 | CETUXIMAB + RT | N | N | 300015614 | PEMBROLIZUMAB |
| 300006274 | 300004362 | 1.83 | 72 | Palliative (P) | 2016-07-23 | 2016-07-23 | NIVOLUMAB | N | N | 300015615 | CISPLATIN |
| 300006275 | 300004362 | 1.49 | 69.5 | Not known (9) | 2017-02-08 | 2017-02-08 | AML 19 TRIAL | N | null | 300015615 | HYDROXYCARBAMIDE |
| 300006276 | 300004363 | 1.73 | null | Palliative (P) | 2015-03-27 | 2015-04-03 | CARBOPLATIN + RT | 02 | Y | 300015624 | CARBOPLATIN |
| 300006277 | 300004363 | 1.61 | 83 | null | 2017-08-22 | 2017-08-29 | Cetuximab + Radiotherapy Maint | 02 | Y | 300015624 | NIVOLUMAB |